MRC1 and colonic neoplasm: Our initial findings indicate that the strategy of combining NSC666715 with TMZ seems to effectively block the growth of both MMR-proficient and MMR-deficient colon cancer cells in vitro and in vivo (data not shown), as we have described in our previous studies [17].